JNJ Filing
4Filing Date: Jun 12, 2026
JOHNSON & JOHNSON (JNJ) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0000200406-26-000127open_in_new
Total Value$3.57M
Trades4
Insiders1
Transaction Details
Wengel Kathryn E
EVP, Chief TO and Risk Officer·Direct
Sell · Dispose
Common Stock
Shares-10.00K
Price$241.15
Total Value$2.41M
Shares Owned After114.29K
Transaction DateJun 11, 2026
Footnotes ▸
This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Wengel Kathryn E
EVP, Chief TO and Risk Officer·Direct
Exercise · Acquire
Common Stock
Shares+10.00K
Price$115.67
Total Value$1.16M
Shares Owned After124.29K
Transaction DateJun 11, 2026
Wengel Kathryn E
EVP, Chief TO and Risk Officer·Direct
Exercise · Dispose
Employee Stock Options (Right to Buy)Derivative
Shares-10.00K
Price$0.00
Total Value$0
Shares Owned After32.97K
Transaction DateJun 11, 2026
ExpiresFeb 13, 2027
Footnotes ▸
Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Wengel Kathryn E
EVP, Chief TO and Risk Officer·Indirect · By ESOP
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After281
Footnotes ▸
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026).
Post-Transaction Holdings
Wengel Kathryn E
| Security | Shares | Change |
|---|---|---|
| Common Stock | 114.57K | - |
| Employee Stock Options (Right to Buy) | 32.97K | -10.00K (-23.27%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-11
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
--- Reporting Owner ---
Name: Wengel Kathryn E
CIK: 0001745955
Role: Officer (EVP, Chief TO and Risk Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-11 | Code: M (Exercise of derivative)
Shares: +10,000 | Price: $115.67
Total Value: $1,156,700.00
Shares Owned After: 124,287.8735 | Ownership: D (Direct)
[Transaction #2]
Security: Common Stock
Date: 2026-06-11 | Code: S (Open market sale)
Shares: -10,000 | Price: $241.15
Total Value: $2,411,500.00
Shares Owned After: 114,287.8735 | Ownership: D (Direct)
Footnotes:
[F1] This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
--- Derivative Transactions ---
[Transaction #1]
Security: Employee Stock Options (Right to Buy)
Date: 2026-06-11 | Code: M (Exercise of derivative)
Shares: -10,000 | Price: $0.00
Exercisable: N/A | Expires: 2027-02-13
Shares Owned After: 32,965 | Ownership: D (Direct)
Footnotes:
[F4] Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: I (Indirect)
Footnotes:
[F2] Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026).
[Holding #2]
Security: Common Stock
Ownership: I (Indirect)
Footnotes:
[F3] Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026).
--- Footnotes (Complete Index) ---
F1: This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026).
F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026).
F4: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
--- Signature ---
/s/ /s/ Joleen Morgan, as attorney-in-fact for Kathryn E. Wengel (2026-06-12)